1 Min Read
Sept 6 (Reuters) - Caladrius Biosciences Inc
* Files for resale of up to 932,204 shares of Co’s common stock by the selling stockholders - SEC filing Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.